S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Thinx Launches Butterfly Shorts to Move Period Care Into Athleisure

Moving beyond the traditional underwear drawer, Thinx is launching Butterfly Shorts, an athletic-inspired garment designed to be worn as visible apparel. The product merges the company’s signature 12-hour leakproof technology with a breathable mesh silhouette, aiming to bridge the gap between functional period protection and everyday activewear.

Thinx Launches Butterfly Shorts to Move Period Care Into Athleisure
Photo: Bio & News

The new shorts, available October 6, 2026, for $56, feature a design intended to withstand everything from morning workouts to long-haul travel. By utilizing Coolcore breathable mesh and an absorbent gusset, the brand is positioning the garment as a standalone item rather than a hidden base layer. This expansion follows the successful rollout of a similar style for teens, with the adult version now offered in a size range of XS through 4X.

Nicole Pawlukowsky, vice president of Thinx, noted that the product aims to remove the limitations often associated with cycle management. By integrating clinical protection into a garment that mimics standard athletic shorts, the company is attempting to shift the category toward a lifestyle-first approach. The release marks a strategic pivot for the Kimberly-Clark-owned brand, emphasizing that consumers should not have to compromise their personal style or movement to maintain reliable coverage throughout the day.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!